Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts by Müllerová H, Hahn B, Simard EP, Mu G, Hatipoğlu U

Get full text

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. by Borrow, P, Lewicki, H, Hahn, B, Shaw, G, Oldstone, M

ANALYSIS OF THE ANTIVIRAL CYTOTOXIC T-LYMPHOCYTE RESPONSE IN PRIMARY HIV-1 by Borrow, P, Lewicki, H, Horwitz, M, Hahn, B, Shaw, G, Oldstone, M

Effects of non-representative sampling design on multi-scale habitat models: flammulated owls in the Rocky Mountains by Chiaverini, L, Wan, HY, Hahn, B, Cilimburg, A, Wasserman, TN, Cushman, SA

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma by Silver J, Bogart M, Packnett E, Wu J, McMorrow D, Hahn B

Get full text

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs by Llanos JP, Ortega H, Bogart M, Packnett ER, Manjelievskaia J, Bell CF, Hahn B

Get full text

Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study by Llanos JP, Bell CF, Packnett E, Thiel E, Irwin DE, Hahn B, Ortega H

Get full text

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy by Moretz C, Hahn B, White J, Goolsby Hunter A, Essoi B, Elliott C, Ray R

Get full text

Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database by Llanos JP, Ortega H, Germain G, Duh MS, Lafeuille MH, Tiggelaar S, Bell CF, Hahn B

Get full text

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenanc... by Moretz C, Cole AL, Mu G, Wu B, Guisinger A, Liu Y, Hahn B, Baylis L

Get full text

Burden of disease associated with a COPD eosinophilic phenotype by Ortega H, Llanos JP, Lafeuille MH, Germain G, Duh MS, Bell CF, Sama SR, Hahn B

Get full text

HIV-host interactions: implications for vaccine design by Haynes, B, Shaw, G, Korber, B, Kelsoe, G, Sodroski, J, Hahn, B, Borrow, P, McMichael, A

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol by Moretz C, Bengtson LGS, Sharpsten L, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R

Get full text

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retr... by Moretz C, Sharpsten L, Bengtson LGS, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R

Get full text

Resistance of transmitted founder HIV-1 to IFITM-mediated restriction by Foster, T, Wilson, H, Iyer, S, Coss, K, Doores, K, Smith, S, Kellam, P, Finzi, A, Borrow, P, Hahn, B, Neil, S

Profiling Disease and Economic Burden in CRSwNP Using Machine Learning by Bhattacharyya N, Silver J, Bogart M, Kponee-Shovein K, Cheng WY, Cheng M, Cheung HC, Duh MS, Hahn B

Get full text

Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. by Jones, N, Wei, X, Flower, DR, Wong, M, Michor, F, Saag, MS, Hahn, B, Nowak, M, Shaw, G, Borrow, P

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Co... by Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B

Get full text

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. by Borrow, P, Lewicki, H, Wei, X, Horwitz, MS, Peffer, N, Meyers, H, Nelson, J, Gairin, J, Hahn, B, Oldstone, M, Shaw, G

P09-21 LB. Deep sequencing of HIV-1 from acute infection: low initial diversity, and rapid but variable CTL escape by Haynes B, Shaw G, Hahn B, Green L, Gleasner C, Han C, Leitner T, Hraber P, Giorgi E, Lo C, Bhattacharya T, Keele B, Fischer W, Korber B